Medications for Lung Disease With Systemic Sclerosis

2 results

  • actemra - tocilizumab injection, solution, concentrate

    (Tocilizumab)
    Genentech, Inc.
    Actemra (tocilizumab) treats moderately to severely active rheumatoid arthritis, giant cell arteritis, SSc-associated interstitial lung disease, polyarticular and systemic juvenile idiopathic arthritis (ages 2+), CAR T cell-induced cytokine release syndrome, and hospitalized COVID-19 patients requiring oxygen support or mechanical ventilation.
    Medication Details
    Drug Interactions

  • ofev - nintedanib capsule

    (Nintedanib)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    OFEV treats adults with idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and slows pulmonary function decline in systemic sclerosis-associated interstitial lung disease (SSc-ILD).
    Medication Details
    Drug Interactions